搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
5 小时
Aging for Amateurs: There are ways to limit your risk of dementia. Here are suggestions
The number of people diagnosed with dementia is skyrocketing worldwide. But treating even common health issues like high ...
34 分钟
Dear Doctor: Can long-term use of gabapentin increase the chances of dementia?
For many years, platinum-based chemotherapy has been one of the mainstays for advanced testicular cancer. Painful peripheral ...
ScienceAlert on MSN
15 小时
Shockingly Common Injury Linked With Increased Risk of Dementia
Older adults who experience injurious falls are more likely to develop dementia within a year of their accident compared to ...
来自MSN
19 小时
New study shows which dreams can be an early tell-tale sign of dementia or Parkinson's disease
Studies have consistently indicated that individuals with REM sleep behavior disorder (RBD), who physically act out their ...
Queen Mary University of London
1 小时
Late-life depression could be an early indicator of dementia
Having depression is known to increase a person’s risk of developing dementia, but depression is also an early indicator of ...
23 小时
on MSN
This Type of Dream Could Indicate Early Onset Dementia or Parkinson's, Study Finds
Scientists say these dreams lead to one of the two diseases in "almost all cases." A new study published in the journal ...
Tyler Morning Telegraph
2 小时
What Do Sleep Medications Do to Your Brain?
MONDAY, Jan. 13, 2025 (HealthDay news) -- The sleep aid Ambien could be allowing toxic proteins to pollute the brain, ...
15 小时
Ketamine could treat Parkinson’s movement disorders
Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's ...
manilatimes
2 小时
Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular ...
NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...
National Health Executive
4 小时
New health facility for safer drug use
The Thistle Centre’s opening marks a significant milestone in Scotland's efforts to reduce the dangers associated with drug ...
clinicaltrialsarena
2 小时
ProMIS Neurosciences launch Phase Ia AβO Alzheimer’s trial
The Phase Ia trial is designed to assess the company’s drug designed to target chemicals thought to be a cause of Alzheimer’s disease.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈